Our Pricing

Best Weight Loss Injection UK - Lowest Prices Available

Published on: June 03, 2026

Finding the best weight loss injection UK lowest price requires comparing licensed treatments, understanding clinical evidence, and choosing a trusted UK pharmacy. At Cured Pharmacy, we offer transparent upfront pricing on all MHRA-licensed weight loss injections—including Mounjaro from £135.00 Wegovy from £135.00 and Saxenda from £135.00—with free online consultation by UK prescribers and discreet next-day delivery across the UK.

How Weight Loss Injections Work: GLP-1 and Dual-Agonist Mechanisms

Weight loss injections licensed in the UK work by mimicking natural gut hormones that regulate appetite and blood sugar. GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda) slow gastric emptying, reduce hunger signals to the brain, and improve insulin secretion [1]. These mechanisms help patients achieve sustained calorie reduction without the intense hunger that often derails traditional dieting.

Tirzepatide (Mounjaro) represents a newer class: dual GIP/GLP-1 receptor agonists. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 pathways simultaneously, tirzepatide produces superior weight loss outcomes compared to single-pathway treatments. In the SURMOUNT-1 trial, participants receiving the highest tirzepatide dose achieved an average 22.5% body weight reduction over 72 weeks—significantly greater than the 14.9% average seen with semaglutide 2.4mg in the STEP-1 trial [1][2].

All injectable weight loss treatments available through Cured Pharmacy are prescription-only medications that require clinical assessment by a UK-registered prescriber. Our pharmacist-led team evaluates your medical history, current medications, and weight loss goals to determine the most appropriate treatment and starting dose for your individual circumstances.

Comparing the Best Weight Loss Injection UK Options

The UK market offers three main injectable weight loss treatments, each with distinct dosing schedules, efficacy profiles, and pricing structures. Understanding these differences helps you make an informed choice suited to your lifestyle and clinical needs.

Mounjaro (tirzepatide) delivers the highest average weight loss in clinical trials and requires just one injection per week. The treatment starts at a lower dose and gradually increases over 16-20 weeks to minimise gastrointestinal side effects, with most patients reaching the maintenance dose that produces optimal results [1]. Wegovy (semaglutide) also offers once-weekly dosing with proven efficacy, making it a convenient option for patients seeking significant weight reduction. Saxenda (liraglutide) requires daily injections but offers flexibility for patients who prefer more frequent, lower-dose administration.

Pricing varies based on dose strength and treatment duration. At Cured Pharmacy, we provide transparent upfront pricing before your consultation, so you know exactly what to expect. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team ensure every prescription meets MHRA safety standards and is appropriate for your individual health profile.

Which Injection Produces the Best Results?

Clinical trial data shows tirzepatide produces the greatest average weight loss, followed by semaglutide, then liraglutide. However, 'best' depends on individual factors including your medical history, tolerance to side effects, dosing preference, and budget. Some patients respond exceptionally well to semaglutide or liraglutide, while others may not tolerate the higher efficacy treatments due to gastrointestinal effects [2][3].

Your UK prescriber will assess your BMI, weight loss goals, previous treatment history, and any contraindications during your free online consultation. This personalised approach ensures you receive the most suitable treatment rather than simply the highest-efficacy option, balancing effectiveness with safety and tolerability.

Real-World Efficacy: What Clinical Trials Show

The SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight with weight-related comorbidities. Participants receiving tirzepatide 15mg (the highest dose) achieved an average 22.5% total body weight reduction at 72 weeks, compared to 2.4% with placebo. Importantly, 63% of participants on the highest dose achieved at least 20% weight loss—a threshold associated with significant improvements in cardiovascular and metabolic health markers [1].

The STEP programme evaluated semaglutide 2.4mg across multiple trials. In STEP-1, participants achieved an average 14.9% body weight reduction over 68 weeks, with 50.5% reaching at least 15% weight loss. The STEP-2 trial specifically studied patients with type 2 diabetes, demonstrating that semaglutide produces meaningful weight loss even in populations with metabolic dysfunction [2][4].

Liraglutide 3.0mg (Saxenda) was studied in the SCALE trials, where participants achieved an average 8% body weight reduction over 56 weeks. While lower than newer treatments, liraglutide remains a valuable option for patients who prefer daily dosing or cannot tolerate higher-efficacy alternatives [3]. All these trials required participants to follow reduced-calorie diets and increase physical activity, emphasising that weight loss injections work best as part of comprehensive lifestyle modification.

Long-Term Weight Maintenance

Clinical trials demonstrate that weight loss is maintained as long as treatment continues, but most patients regain weight if they discontinue the medication. The STEP-4 trial showed that participants who stopped semaglutide regained approximately two-thirds of their lost weight within one year [4]. This highlights that GLP-1 and dual-agonist treatments are long-term interventions rather than short-term solutions.

At Cured Pharmacy, our clinical team provides ongoing support and monitoring throughout your treatment journey. Regular follow-up consultations help optimise your dose, manage any side effects, and adjust your treatment plan as your weight loss progresses. This continuity of care improves adherence and long-term outcomes.

Lowest Price Weight Loss Injections: Transparent UK Pharmacy Pricing

Cured Pharmacy guarantees the lowest prices on UK-licensed weight loss injections, with transparent pricing displayed before you begin your consultation. We believe patients deserve to know costs upfront rather than discovering prices only after completing lengthy assessments.

Our pricing structure reflects genuine UK-sourced medications dispensed by our GPhC-registered pharmacy (9012511). Every prescription includes free consultation with a UK prescriber, discreet packaging, and tracked delivery. We never compromise on quality or safety to offer competitive pricing—all medications are sourced through licensed UK wholesalers and meet MHRA standards.

Many patients find that investing in clinically proven weight loss treatment delivers better value than years of ineffective over-the-counter products or costly commercial weight loss programmes. When you consider the metabolic health improvements, reduced risk of obesity-related complications, and quality of life benefits, prescription weight loss injections represent a cost-effective intervention for eligible patients [5].

Who Can Use Weight Loss Injections in the UK?

NICE guidelines recommend considering GLP-1 receptor agonists for weight management in adults with a BMI of 35 kg/m² or greater, or 32.5 kg/m² or greater for people from Black, Asian, or other minority ethnic groups [6]. Patients with a BMI of 30 kg/m² or greater who have weight-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea may also be suitable candidates.

Weight loss injections are not appropriate for everyone. Contraindications include pregnancy or breastfeeding, personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and previous pancreatitis. Your UK prescriber will review your full medical history and current medications to identify any contraindications or drug interactions before prescribing [3][6].

Our online consultation takes under three minutes and covers your medical history, current health status, weight loss goals, and previous treatment attempts. A UK-registered prescriber reviews every consultation individually—there are no automatic approvals. If weight loss injections are not suitable for you, our clinical team will explain why and suggest alternative approaches or refer you back to your GP for further assessment.

Managing Side Effects Safely

The most common side effects of GLP-1 and dual-agonist injections are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These effects are usually mild to moderate, occur most frequently during dose escalation, and typically diminish over time as your body adjusts [1][2][3]. Starting at a low dose and gradually increasing helps minimise these symptoms.

Rare but serious side effects include pancreatitis, gallbladder disease, and acute kidney injury (usually secondary to severe dehydration from vomiting or diarrhoea). Patients should seek immediate medical attention if they experience severe abdominal pain, persistent vomiting, or signs of dehydration. Our clinical team provides detailed safety information and ongoing monitoring throughout your treatment to identify and manage side effects promptly.

How to Buy Weight Loss Injections Online Safely in the UK

Purchasing prescription weight loss injections online requires using a registered UK pharmacy with qualified prescribers. Cured Pharmacy is registered with the General Pharmaceutical Council (GPhC registration 9012511), and all our prescribers are UK-registered clinicians operating under GMC or GPhC oversight.

Beware of websites offering weight loss injections without a prescription, claiming to source medications from overseas, or selling products at prices significantly below market rates. These sites often supply counterfeit, expired, or improperly stored medications that pose serious health risks. The MHRA regularly issues warnings about fake semaglutide and tirzepatide products entering the UK market [7].

Our process ensures safety and legality at every step: complete a clinical consultation reviewed by a UK prescriber, receive approval and prescription if appropriate, have your medication dispensed by our GPhC-registered pharmacy, and receive discreet delivery with full patient information leaflets and injection instructions. We also provide ongoing clinical support via phone or email if you have questions or concerns during treatment.

Next-Day Discreet Delivery Across the UK

Once your prescription is approved, we dispense your medication the same day for next-day delivery to any UK address. All packages use plain, unmarked packaging with no external indication of contents, ensuring complete discretion. Medications requiring refrigeration are shipped in validated cold-chain packaging with temperature monitoring to maintain product integrity.

We use tracked courier services so you can monitor your delivery in real-time. If you're not home when delivery is attempted, the courier will leave a card with collection instructions or rearrange delivery for a more convenient time. Our pharmacy team is available by phone (+44 116 4646009) if you have any delivery queries or special requirements.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
7. Medicines and Healthcare products Regulatory Agency. (2023). Falsified semaglutide injection pens identified in the UK. Drug Safety Update, 16(10). https://www.gov.uk/drug-safety-update/falsified-semaglutide-injection-pens-identified-in-the-uk [accessed 13 August 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, diet, exercise, and other lifestyle factors. Cured Pharmacy does not guarantee specific outcomes.